Cullinan Oncology Completes $98.5 Million Series B Financing
Go back to Cullinan Oncology Completes $98.5 Million Series B Financing| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 67.21 +1.16 (1.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.05 | 52 Week High | $77.12 | |||
| Open | $66.80 | 52 Week Low | $49.03 | |||
| Day High | $68.64 | P/E | 43.64 | |||
| Day Low | $66.61 | EPS | $1.54 | |||
| Volume | 5,937,791 | |||||
| MACROGENICS (NASDAQ: MGNX) | Delayed: 4.17 +0.08 (1.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.09 | 52 Week High | $36.11 | |||
| Open | $4.16 | 52 Week Low | $14.84 | |||
| Day High | $4.25 | P/E | 10.69 | |||
| Day Low | $4.11 | EPS | $0.39 | |||
| Volume | 143,955 | |||||
